BioXcel Therapeutics Inc (BTAI)
2.61
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 16:00
2.61
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics Total Assets (Quarterly): 73.70M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.70M |
| September 30, 2023 | 100.45M |
| June 30, 2023 | 140.10M |
| March 31, 2023 | 180.10M |
| December 31, 2022 | 205.85M |
| September 30, 2022 | 244.82M |
| June 30, 2022 | 248.24M |
| March 31, 2022 | 211.04M |
| December 31, 2021 | 239.44M |
| September 30, 2021 | 261.33M |
| June 30, 2021 | 281.11M |
| March 31, 2021 | 200.39M |
| December 31, 2020 | 219.94M |
| Date | Value |
|---|---|
| September 30, 2020 | 238.75M |
| June 30, 2020 | 70.46M |
| March 31, 2020 | 85.81M |
| December 31, 2019 | 36.39M |
| September 30, 2019 | 43.70M |
| June 30, 2019 | 34.28M |
| March 31, 2019 | 40.33M |
| December 31, 2018 | 43.55M |
| September 30, 2018 | 47.87M |
| June 30, 2018 | 51.21M |
| March 31, 2018 | 56.32M |
| December 31, 2017 | 1.355M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
34.28M
Minimum
Jun 2019
281.11M
Maximum
Jun 2021
163.99M
Average
200.39M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Synlogic Inc | 75.55M |
| Cormedix Inc | 82.06M |
| Bristol-Myers Squibb Co | 95.16B |
| Verastem Inc | 149.72M |
| Ocular Therapeutix Inc | 252.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 130.21M |
| Shareholders Equity (Quarterly) | -56.51M |
| Debt to Equity Ratio | -1.780 |
| Current Ratio | 2.646 |
| Net Debt Paydown Yield | -2.02% |